Topical Corticosteroids Market, by Formulation (Creams, Ointments, Gels, Others), by Application (Acne, Dermatitis, Psoriasis, Eczema, Hyperpigmentation, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jun 2022

Code : CMI5035

Pages :150

Formats :

Excel and PDF

Industry : Pharmaceutical

Topical Corticosteroids MarketSize and Trends

Global topical corticosteroids (steroids) market is estimated to be valued at US$ 4.12 Bn in 2022, and is expected to exhibit a CAGR of 4.36 % over the forecast period (2022-2030).

Figure 1: Global Topical Corticosteroids (steroids) Market Share (%) Analysis, By Formulation, 2022

Increasing number of cases of eczema and atopic dermatitis is the major factor that is expected to drive growth of global topical corticosteroids (steroids) market over the forecast period.

Increasing number of eczema & atopic dermatitis is expected to drive growth of the global topical corticosteroids (steroids) market. For instance, according to the Allergy & Asthma Network, around 31.6 million people in the U.S. had eczema in 2020, with 15% of children and 7.3 % adults having atopic dermatitis

Market- Trends

Increasing number of research and development activities related to topical corticosteroids by market players is expected to aid in growth of the global topical corticosteroids (steroids) market over the forecast period. For instance, in April 2022, Eli Lilly and Company, a global healthcare company, announced that Lebrikizumab, an IL-13 inhibitor, significantly improved disease severity when combined with topical corticosteroids (TCS) in people with moderate-to-severe atopic dermatitis (AD) in third pivotal Phase 3 trial (ADhere).